Following voters passing a ballot measure back in November, Governor Phil Murphy has signed three bills into law, which legalizes adult use cannabis in the state of New Jersey. The legislation creates a commission tasked with issuing regulations by June this year.
In this three-part series, cannabis lawyer and compliance expert Todd Feldman takes a look at how laws shape California’s supply chain, constrains business practices and affects the cost of doing business. In Part Three, we analyze local regulations.
According to a press release, A2LA accredited Cannalytics to ISO 17025:2017, making it the first cannabis testing laboratory to attain accreditation in Puerto Rico.
The post Cannalytics Becomes First Accredited Cannabis Lab in Puerto Rico appeared first on Cannabis Industry Journal.
In this series, Aaron Green sits down and interviews a number of integrated cannabis companies and flower brands. In Part 1, Green chats with Sam Ghods, CEO at Connected, to learn more about how he got into cannabis and Connected’s product and branding strategy.
The post Flower-Side Chats Part 1: A Q&A with Sam Ghods, CEO of Connected appeared first on Cannabis Industry Journal.
There has been an explosion of interest in THCV recently, as well as a number of other uncommon cannabinoids. There will be big winners and losers in rare cannabinoid markets, but at the end of the day, the highest quality and lowest cost producers will capture most of these markets.
On January 15, 2021, the USDA published its final rule on US hemp production. Producers will not be required to use a DEA reverse distributor or law enforcement to dispose of non-compliant plants. Instead, producers will be able to use common on-farm practices for disposal.
In a press release published last week, the two companies announced they have entered an agreement for Jazz to acquire GW Pharma, the producer of the only FDA-approved CBD medication Epidiolex, for a total of $7.2 billion.